课题基金 / 基金详情

Girk2/3 channels in cartilage biology and disease

Girk2/3 channels in cartilage biology and disease
Girk2/3 通道在软骨生物学和疾病中的作用
批准号:
9902333
负责人:
Jennifer J Westendorf
金额:
$17.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2022-03-31

项目摘要

项目成果

Jennifer J Westendorf的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 长骨是通过软骨内骨化过程形成和修复的。我们的目标是 了解软骨内骨生长的分子机制,并应用这些知识来改善 肌肉骨骼组织再生和愈合。为了实现这个目标,我们有了一个新的发现, 软骨细胞和成骨细胞系细胞表达称为GIRKs的离子通道,控制钾离子转运 在G蛋白偶联受体激活后,穿过细胞膜并激活细胞内程序。我们 证明GIRK亚基在软骨细胞和成骨细胞系细胞中表达,但不表达GIRK亚基。 破骨细胞缺乏Girk 2和Girk 3的动物骨骼明显更长更密,这表明 当Girk 2和Girk 3缺失或失活时,软骨和骨形成更大。的中心假设 该项目是Girk 2和Girk 3协同调节软骨细胞和成骨细胞的存活、增殖 和/或在软骨内骨发育期间成熟。我们的具体目标是:1)确定Girk 2 和Girk 3调节生长板软骨细胞成熟,2)定义Girk 2和Girk 3如何有助于 成骨细胞谱系成熟和骨密度,以及3)确定由Girk 2和Girk 3形成的通道是否 软骨细胞和成骨细胞中阿片样物质诱导的反应所需。这项工作的意义在于, Girk 2和Girk 3是潜在的可药物化靶标,其活性和/或表达可以被控制以 加速长骨生长和愈合。
英文摘要
ABSTRACT Long bones are formed and repaired through the process of endochondral ossification. Our goal is to understand molecular mechanisms of endochondral bone growth and apply that knowledge to improve musculoskeletal tissue regeneration and healing. Towards this goal, we made the novel discovery that chondrocyte- and osteoblast-lineage cells express ion channels called GIRKs that control potassium transport across cell membranes and activate intracellular programs after activation of G-protein-coupled receptors. We demonstrate that GIRK subunits are expressed in chondrocyte- and osteoblast-lineage cells, but not osteoclasts. Animals lacking both Girk2 and Girk3 have remarkably longer and denser bones, suggesting greater cartilage and bone formation when Girk2 and Girk3 are absent or inactivated. The central hypothesis of this project is that Girk2 and Girk3 cooperate to regulate chondrocyte and osteoblast survival, proliferation and/or maturation during endochondral bone development. Our specific aims are to: 1) determine how Girk2 and Girk3 regulate growth plate chondrocyte maturation, 2) define how Girk2 and Girk3 contribute to osteoblast-lineage maturation and bone density, and 3) determine if channels formed by Girk2 and Girk3 are required for opioid-induced responses in chondrocytes and osteoblasts. The significance of this work is that Girk2 and Girk3 are potentially druggable targets whose activities and/or expression could be controlled to accelerate long bone growth and healing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phlpp phosphatases in osteoarthritis
  • 批准号:
    10707868
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2022
  • 负责人:
    Jennifer J Westendorf
  • 依托单位:
Phlpp phosphatases in osteoarthritis
  • 批准号:
    10318360
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2022
  • 负责人:
    Jennifer J Westendorf
  • 依托单位:
Girk2/3 channels in cartilage biology and disease
  • 批准号:
    9755834
  • 项目类别:
  • 资助金额:
    $20.99万
  • 财政年份:
    2019
  • 负责人:
    Jennifer J Westendorf
  • 依托单位:
Protein Phosphatase Phlpp1 in Cartilage Development & Osteoarthritis Progression
  • 批准号:
    9316518
  • 项目类别:
  • 资助金额:
    $34.98万
  • 财政年份:
    2014
  • 负责人:
    Jennifer J Westendorf
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: